📢 Attention undergrads & first-year med students! Apply now for Fred Hutch’s 8-week Summer Internship on Infectious Diseases in the Imunocompromised Host! Hands-on research + expert mentorship in state-of-the-art labs. 🦠 Apply by Jan. 30, 2026: https://bit.ly/48K89SV

Fred Hutch is recruiting a full-time Associate Professor in the Translational Science & Therapeutics Division. We are seeking candidates with expertise in hematopathology and molecular pathology, and interest in #HSCT, #IMTX and lymphoid neoplasms. Apply: https://apply.interfolio.com/178338

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, researchers and patient advocates in attendance. Learn more about the research from Fred Hutch physician-scientists. #SABCS25 https://bit.ly/4p6mgGR

When Margie Wilson was diagnosed with endometrial cancer she knew nothing about cancer. She didn’t even know what an oncologist does. A decade later, she is a vocal patient advocate and a program manager with the Endometrial Cancer Action Network for African Americans. https://bit.ly/45b1lvh

@fredhutch.org researchers, including our own Li Hsu, have created a free tool to assess their colorectal cancer risk online. MyGeneRisk combines lifestyle information and optional genetic data, returns results immediately, and does not store personal data. 🔗 mygenerisk-colon.fredhutch.org

Treating adults with #ALL is very complex. To help clinicians and researchers recognize common challenges, I offer this paper. Based on years of treating this disease @fredhutch.org, @uwmedicine.bsky.social, and community partners. pubmed.ncbi.nlm.nih.gov/41056518/ #MedSky #HemOnc

🎙️ In this episode of Oncology Insights, Dr. Petros Grivas chats with Dr. Vidhya Nair about breakthroughs in #breastcancer care — personalized treatments, clinical trials, genetic testing & supportive services driving better outcomes. https://bit.ly/4j3mKwj

Our 2025 Annual Report highlights some of the specific accomplishments of the past year and illustrates our ongoing commitment to our patients, our people and our community: https://bit.ly/48XYt6f

Fred Hutch's Immunotherapy Integrated Research Center is recruiting an Open Rank Faculty position to lead a laboratory-based program focused on tumor immunology and cancer immunotherapy with a strong vision/path toward clinical translation. Learn more: https://apply.interfolio.com/176403

@rahulbanerjeemd.bsky.social of @fredhutch.org discusses major advances in bispecific antibodies presented at #ASH25 for #multipleMyeloma. Read and watch more here: ➡️ https://bit.ly/3KMNsg0 #myeloma #mmsm

@biorxivpreprint.bsky.social NKTR-255 is a polymer-conjugated IL-15 with extended half-life that can boost endogenous T and NK cells, as well as CD19 CAR-T activity in B cell malignancies @sriv4000.bsky.social @fredhutch.org www.biorxiv.org/content/10.6...

New work from Fred Hutch's Dr. Alexandra Willcox and collaborators shows the human gene AMOTL2 helps fight Zika virus by boosting type I interferon response — creating antiviral proteins that block the virus. @pnas.org https://bit.ly/3MD2rth

Did you know we have a podcast? The Formicary is a collection of interviews done on stream sciants.com/the-formicary New episode out on HIV/AIDS research with researchers from @fredhutch.org! youtu.be/jbdHdW3eWJE #scicomm #stem #podcast #science #sciants

Check out our latest #YouTube video where we discuss HIV/AIDS research with Dr.Rachel Bender Ignacio, a physician-scientist and leading infectious-disease researcher at @fredhutch.org --and is a driving force behind cutting-edge HIV/AIDS research worldwide. youtu.be/EGuGKWj4Eao

DUX4-induced HSATII RNA accumulation drives protein aggregation impacting RNA processing pathways, say Tessa Arends, Sean Bennett, and Stephen Tapscott @fredhutch.org: rupress.org/jcb/article/... #Disease #RNAbiology

Fred Hutch is recruiting a full-time Associate Professor in the Translational Science & Therapeutics Division. We are seeking candidates with expertise in hematopathology and molecular pathology, and interest in #HSCT, #IMTX and lymphoid neoplasms. Apply: https://apply.interfolio.com/178338

It’s been a tough week for many across Washington. Here’s a reminder that brighter skies are ahead. Our hearts are with everyone impacted by flooding in the Pacific Northwest. Stay safe, stay connected, and know we’re thinking of you. 💙

New work from Fred Hutch's Dr. Alexandra Willcox and collaborators shows the human gene AMOTL2 helps fight Zika virus by boosting type I interferon response — creating antiviral proteins that block the virus. @pnas.org https://bit.ly/3MD2rth

Need tips on how to deal with holiday eating? Our dietitian, Laura Martinell, has some advice from her #nutrition column in The Beam newsletter. Though this article references Thanksgiving, the tips are useful for all holiday feasting as well as any time of the year. https://bit.ly/47QcN1c

In honor of the late Dr. Eddie Méndez, @fredhutch.org is seeking applications for the 8th Annual Dr. Eddie Méndez Scholar Award which recognizes outstanding and diverse postdocs who are conducting cancer, infectious disease or basic science research. https://apply.interfolio.com/176955

Fred Hutch at #SABCS25: Catch Dr. Lynn Symonds present "Clinical Feasibility and Reproducibility of Tumor Infiltrating Lymphocyte (TIL) Reporting for Early-Stage Triple Negative Breast Cancer Patients" 👉 https://bit.ly/3MOsY6U

Fred Hutch at #SABCS25: Don't miss Dr. Jennifer Specht present "Fdg-pet to assess therapeutic response in patients with bone-dominant metastatic breast cancer" 👉 https://bit.ly/4aB9eNZ

Last seminar of 2025: Dr. @sanjaysrivatsan.bsky.social from @fredhutch.org discussed capsule-based genome sequencing and lineage tracing. Thank you to everyone who joined us in person and via Zoom. Recording available on our YouTube channel: youtu.be/ykS0q7Pl3xo?... @jlmcfalinefigueroa.bsky.social

Fred Hutch at #SABCS25: Catch Dr. Meghan Flanagan present "Omission of sentinel lymph node biopsy among women age 50-70" 👉 https://bit.ly/3MiaETP

Fred Hutch at #SABCS25: Catch Dr. Sara Hurvitz present "Safety analysis of ASCENT-03, a phase 3 study of sacituzumab govitecan" 👉 https://bit.ly/4oKawKi

.@fredhutch.org is seeking applications for the 8th Annual Dr. Eddie Méndez Scholar Award which recognizes outstanding postdoctoral fellows from any discipline who are conducting cancer, infectious disease or basic science research. Learn more and apply: https://apply.interfolio.com/176955

Fred Hutch at #SABCS25: Don't miss Dr. Heather Parsons present on multiple topics, "Discussant for GS1-05, GS1-06, GS1-07" 👉 https://bit.ly/4pk8FNc

Zanubrutinib Plus Venetoclax Displays Long-Term PFS Benefit in Untreated CLL/SLL @ash.hematology.org @fredhutch.org @mshadman.bsky.social #ASH25 #oncology #leusm #lymsm www.onclive.com/view/zanubru...

Today we celebrated the retirement of research administration manager Katrina Akioka after 13 years @fredhutch.org. She leaves behind a legacy of service to Fred Hutch, the division, and the many faculty and labs she supported over the years. We wish her all the best in retirement.

Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO

Catching up at #ash25 with 2 great scientists @fredhutch.org Kate Markey & @mskcancercenter.bsky.social Susan Dewolf

Fred Hutch at #ASH25: Catch Dr. Stefan Radtke present "In Vivo hematopoietic stem cell (#HSC) engineering and selection with CD90-targeted multiplexed virus-like particles (MVPs) for HSC #genetherapy and cancer #immunotherapy" 👉 https://bit.ly/4pTX3AA

Fred Hutch at #ASH25: Catch Dr. Mazyar Shadman present "CAR T cell therapy referral patterns and characteristics of patients with relapsed or refractory (R/R) large B cell lymphoma (LBCL) in the United States" 👉 https://bit.ly/3MFUO5i

Fred Hutch at #ASH25: Catch Dr. Emily Liang present "High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in #CARTcelltherapy recipients" 👉 https://bit.ly/4rCgeQL

Fred Hutch at #ASH25: Catch Dr. Jennifer Huang present "Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic #leukemia" #CLL 👉 https://bit.ly/4rTooEO

Fred Hutch's Min Fang presenting work at #ASH25 showing chromosome genomic array testing (CGAT) improves diagnostic yield in patients with #AML and #MDS and has the potential for better risk stratification - an NCI myeloMATCH and @swog.org report. ashpublications.org/blood/articl...

Fred Hutch's Xiaoyu Qu presenting work at #ASH25 on improving karyotype success for myeloMATCH. Enhanced workflows boosted karyotype yield in AML samples, ensuring more patients receive accurate cytogenetic data for precision trial enrollment. ashpublications.org/blood/articl...

Fred Hutch at #ASH25: Dr. Danielle Kirkey & team identified CLEC2A as a cancer-specific antigen in AML — silent in normal cells, enriched in high-risk KMT2A-r AML. CLEC2A CAR T cells showed strong preclinical efficacy & head to clinical trials in 2026. #AML #CARTherapy

Congrats to Dr. Storb recipient of the Wallace H. Coulter Award for Lifetime Achievement in Hematology. Dr. Storb is recognized for more than 60 years of pioneering work that shaped hematopoietic stem cell transplantation & advanced care of patients with blood disorders. #ASH25 #HemeSky

Fred Hutch at #ASH25: Catch Rasika Venkataraman present "DDX41-R525H mutation promotes dysplastic hematopoiesis via aberrant splicing of key regulators of HSC biology" 👉 https://bit.ly/4iBRuUJ

Well deserved recognition to one of the giants of our field @fredhutch.org Dr. Storb #ash25 #bmtsm

Congrats to Fred Hutch #HSCT pioneer Dr. Rainer Storb on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25! 🩸 👉 bit.ly/3MkdPdx

Fred Hutch at #ASH25: Catch @julieboiko.bsky.social#ASH25present "CSF-1R+ macrophages orchestrate human skin chronic graft-versus-host disease" 👉 https://bit.ly/48jvqLc

Fred Hutch at #ASH25: Don't miss #HSCT pioneer Dr. Rainer Storb receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology! 🩸 👉 https://bit.ly/3MkdPdx

Congratulations to Aida de la Cruz, lab manager in the @harmitmalik.bsky.social Lab, on receiving the Hutchison Award! The award, presented by @fredhutch.org SPAC and named for Dr. Nancy Hutchison, recognizes phenomenal mentorship. It also comes with an awesome personalized bobblehead.

In time for #ASH25, glad to be able to share this work in #TCT. 🔑 1. For many pts, barrier to HCT/CAR T isn't medical, but instead logistical issues like needing a caregiver or local housing. 🔑 2. These reqs aren't well tracked & vary widely between centers www.sciencedirect.com/science/arti...

Fred Hutch at #ASH25: Catch Dr. Christopher Su discuss adverse financial events and delayed treatment initiation among patients with hematologic malignancies. 👉 https://bit.ly/3MHg8Y7

Fred Hutch at #ASH25: Catch Dr. Motoko Koyama present " IFNγ-driven MHC class II expression by intestinal epithelial cells dictates local cytolytic Th1 cell differentiation and intestinal stem cell loss" 👉 https://bit.ly/4rFnrzM

Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO

Fred Hutch at #ASH25: Catch @aportugu.bsky.social#ASH25present: "Real-world outcomes with elranatamab in multiple myeloma: A multi-center analysis from the United States multiple myeloma immunotherapy consortium." 👉 https://bit.ly/3MkulKu